VHAM
HURA

Van Hulzen Asset Management’s TuHURA Biosciences HURA Stock Holding History

Van Hulzen Asset Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$5 – 1164
2024
Q4 		$5 Buy
+1
New +$5 ﹤0.01% 1164

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ST
Sabal Trust St. Petersburg, Florida $1.8B AUM 8.75% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return

Van Hulzen Asset Management's HURA Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of TuHURA Biosciences (HURA) in Q1 2025, closing a stake of 1 share — an estimated $5 sold.

Van Hulzen Asset Management first reported a position in HURA in Q4 2024 and held it in 1 quarter. The position peaked at $5 in Q4 2024. 27 funds tracked by Wall St. Rank hold HURA as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining TuHURA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 1 TuHURA Biosciences share in Q1 2025, an estimated $5.
  • Van Hulzen Asset Management first reported a position in TuHURA Biosciences in Q4 2024 and held it in 1 quarter.
  • Van Hulzen Asset Management's TuHURA Biosciences position peaked at $5 in Q4 2024.
  • 27 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.